FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q92820217> ?p ?o ?g. }

• Q92820217 description "article scientifique publié en 2019" @default.
• Q92820217 description "artículu científicu espublizáu en xunu de 2019" @default.
• Q92820217 description "scientific article published on 17 June 2019" @default.
• Q92820217 description "wetenschappelijk artikel" @default.
• Q92820217 description "наукова стаття, опублікована 17 червня 2019" @default.
• Q92820217 name "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 name "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 type Item @default.
• Q92820217 label "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 label "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 prefLabel "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 prefLabel "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 P1433 Q92820217-0EB1ADFD-6A6B-452C-8CDE-0CC7154C906E @default.
• Q92820217 P1476 Q92820217-3A004892-13FC-407F-946E-4587F49ACA1F @default.
• Q92820217 P2093 Q92820217-2D765B95-A3E0-45C1-AFB3-D6CE4AF5553C @default.
• Q92820217 P2093 Q92820217-3D2D415A-41E7-419B-8CA1-3A11BE3C6D33 @default.
• Q92820217 P2093 Q92820217-6C949BA7-D22B-4687-979E-69E856D231EB @default.
• Q92820217 P2093 Q92820217-888BE257-5B36-4366-8E81-A6D8B19E6F98 @default.
• Q92820217 P2093 Q92820217-8CEAA0D3-D6D7-498A-8A72-D0C64C3E5E6A @default.
• Q92820217 P2093 Q92820217-A21AC9B7-93D8-4428-BB84-9C77E0394778 @default.
• Q92820217 P2093 Q92820217-A3758BDF-0D18-4F63-91FB-94448CDD1FBC @default.
• Q92820217 P2093 Q92820217-A6E0CC6A-BD68-47F0-B086-AD3246ABED9B @default.
• Q92820217 P2093 Q92820217-AD150C65-86FD-4FF3-AD42-BEAE4CDCA023 @default.
• Q92820217 P2093 Q92820217-BB73FD9C-2DC8-42DF-AF04-9605787C5386 @default.
• Q92820217 P2093 Q92820217-CADD4309-1D04-44E7-BCA9-0C69517148B3 @default.
• Q92820217 P2093 Q92820217-F9950609-BA0F-46FC-ABB9-87ACC4878666 @default.
• Q92820217 P2507 Q92820217-8C4AF391-B194-4381-BB64-15D580DE2920 @default.
• Q92820217 P2860 Q92820217-01FABDA5-37F7-4385-94B8-6A6E7A031A01 @default.
• Q92820217 P2860 Q92820217-0E9D4F84-CC9D-434D-85F5-C5711FF29B77 @default.
• Q92820217 P2860 Q92820217-20A5E234-B736-428B-9FA2-F75C88CA7980 @default.
• Q92820217 P2860 Q92820217-20CF3842-A50A-4A43-A052-E82B59DBC5E0 @default.
• Q92820217 P2860 Q92820217-30B033E9-0E75-43B8-A0E8-4F2CA9B59D47 @default.
• Q92820217 P2860 Q92820217-3FA2E312-44A1-4A33-BDEC-EC5943727446 @default.
• Q92820217 P2860 Q92820217-5A771103-2607-4065-8F75-1662C0DEF1BF @default.
• Q92820217 P2860 Q92820217-5D620014-6B25-4D7C-A623-0A7467A2619D @default.
• Q92820217 P2860 Q92820217-715D6AA9-A813-4A30-9207-84422B84B525 @default.
• Q92820217 P2860 Q92820217-74B13FA2-BECE-450D-96C0-0AB442C575A2 @default.
• Q92820217 P2860 Q92820217-7C275D3D-3AEA-42D0-80A6-D62BCEA28CBB @default.
• Q92820217 P2860 Q92820217-7D40FCED-C1CF-4B1D-ABB4-B52665BD83BA @default.
• Q92820217 P2860 Q92820217-8C029578-210B-4FA8-852F-2E98211ACEFC @default.
• Q92820217 P2860 Q92820217-8D307873-00FD-4A2F-859F-4928DCB5DE35 @default.
• Q92820217 P2860 Q92820217-90072CF5-9794-4265-84DF-3323E55C1649 @default.
• Q92820217 P2860 Q92820217-99A299F8-3722-44DA-A0F8-649BC8623F05 @default.
• Q92820217 P2860 Q92820217-A497A1C0-DF45-4357-986B-3DE802416D87 @default.
• Q92820217 P2860 Q92820217-B45255B9-A713-45F9-A7F8-7C186148A7F5 @default.
• Q92820217 P2860 Q92820217-B53FE535-6A8E-4E57-B615-DA7D638C6857 @default.
• Q92820217 P2860 Q92820217-BFA75739-9669-4D45-B471-C5BE9F8D169D @default.
• Q92820217 P2860 Q92820217-C097068F-6A9B-43BC-87C2-BBEF95CC0FB3 @default.
• Q92820217 P2860 Q92820217-E29B1572-36C0-4E8C-AB64-EDC88D153392 @default.
• Q92820217 P2860 Q92820217-E74BE0B5-9765-4E79-83BC-06F8E29C2BA5 @default.
• Q92820217 P2860 Q92820217-EA2BF54E-E31D-49BB-B027-984B505FCFDB @default.
• Q92820217 P2860 Q92820217-F775110C-1506-4A07-A61C-7F536C7FD033 @default.
• Q92820217 P2860 Q92820217-FC73204B-0873-41DC-AB11-4415794096B7 @default.
• Q92820217 P304 Q92820217-2D54B658-419B-4606-A1E4-BDEBB061A2DA @default.
• Q92820217 P31 Q92820217-30D01A41-C3EE-432C-89D1-20DB4E77F438 @default.
• Q92820217 P356 Q92820217-61983460-EFEF-49FA-9B0E-423560E63CC9 @default.
• Q92820217 P433 Q92820217-C05AEDD2-8240-47CF-B53D-FB54A4A42C8F @default.
• Q92820217 P478 Q92820217-246CEEAD-3E84-4BDD-B554-505B1747072E @default.
• Q92820217 P50 Q92820217-80BD82D2-C02C-41E1-86B0-7E16B82BE92C @default.
• Q92820217 P50 Q92820217-E60CFF8B-339C-48CD-B70D-CE6F0DBC67D8 @default.
• Q92820217 P50 Q92820217-FE14E869-889F-4E9A-A1C1-475127AC5280 @default.
• Q92820217 P577 Q92820217-43820635-4238-4558-88E0-2991CE154D7C @default.
• Q92820217 P698 Q92820217-3CD446D5-8E60-4251-B398-76492E85F1FA @default.
• Q92820217 P921 Q92820217-1298D147-5C1B-47CB-AFA6-4FD6E38FA52D @default.
• Q92820217 P932 Q92820217-083DCD25-7945-4650-8D11-48AB1F4942F4 @default.
• Q92820217 P356 S13063-019-3409-1 @default.
• Q92820217 P698 31208472 @default.
• Q92820217 P1433 Q7840023 @default.
• Q92820217 P1476 "iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy" @default.
• Q92820217 P2093 "Beatriz Mothe" @default.
• Q92820217 P2093 "Eric Florence" @default.
• Q92820217 P2093 "Félipe Garcia" @default.
• Q92820217 P2093 "Guido Vanham" @default.
• Q92820217 P2093 "Joeri Aerts" @default.
• Q92820217 P2093 "Jozefien Buyze" @default.
• Q92820217 P2093 "Kris Thielemans" @default.
• Q92820217 P2093 "Lorna Leal" @default.
• Q92820217 P2093 "Montse Plana" @default.
• Q92820217 P2093 "Rob Gruters" @default.
• Q92820217 P2093 "Sabine Allard" @default.
• Q92820217 P2093 "iHIVARNA consortium" @default.
• Q92820217 P2507 Q91967808 @default.
• Q92820217 P2860 Q28710019 @default.
• Q92820217 P2860 Q28740354 @default.
• Q92820217 P2860 Q30934059 @default.
• Q92820217 P2860 Q33896523 @default.
• Q92820217 P2860 Q34351326 @default.
• Q92820217 P2860 Q34422110 @default.
• Q92820217 P2860 Q34646987 @default.
• Q92820217 P2860 Q34664829 @default.
• Q92820217 P2860 Q35005192 @default.
• Q92820217 P2860 Q37407598 @default.
• Q92820217 P2860 Q37486401 @default.
• Q92820217 P2860 Q37802553 @default.
• Q92820217 P2860 Q38071900 @default.
• Q92820217 P2860 Q38463894 @default.
• Q92820217 P2860 Q38692205 @default.
• Q92820217 P2860 Q38812261 @default.
• Q92820217 P2860 Q38827765 @default.
• Q92820217 P2860 Q39550591 @default.

• next